X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (2458) 2458
humans (2429) 2429
life sciences & biomedicine (2373) 2373
anaplastic lymphoma kinase (1570) 1570
oncology (1217) 1217
female (1185) 1185
male (1154) 1154
middle aged (882) 882
lymphomas (866) 866
adult (803) 803
aged (635) 635
anaplastic large cell lymphoma (628) 628
receptor protein-tyrosine kinases - genetics (587) 587
hemic and lymphatic diseases (560) 560
immunohistochemistry (540) 540
lung neoplasms - genetics (540) 540
lymphoma, large-cell, anaplastic - pathology (527) 527
pathology (527) 527
mutation (507) 507
lung cancer (476) 476
lung neoplasms - drug therapy (423) 423
hematology (416) 416
crizotinib (399) 399
lung neoplasms - pathology (392) 392
cancer (391) 391
receptor protein-tyrosine kinases - metabolism (364) 364
carcinoma, non-small-cell lung - drug therapy (361) 361
alk (355) 355
lymphoma (354) 354
carcinoma, non-small-cell lung - genetics (352) 352
receptor protein-tyrosine kinases (347) 347
animals (346) 346
prognosis (323) 323
aged, 80 and over (321) 321
gene rearrangement (318) 318
chemotherapy (313) 313
kinases (313) 313
tumors (312) 312
adolescent (308) 308
lymphoma, large-cell, anaplastic - genetics (306) 306
protein kinase inhibitors - therapeutic use (293) 293
child (291) 291
anaplastic large-cell lymphoma (286) 286
anaplastic lymphoma kinase - genetics (282) 282
antineoplastic agents - therapeutic use (278) 278
protein-tyrosine kinases - genetics (273) 273
lung cancer, non-small cell (266) 266
non-small cell lung cancer (262) 262
in situ hybridization, fluorescence (258) 258
lymphoma, large-cell, anaplastic - metabolism (258) 258
cell line, tumor (257) 257
care and treatment (254) 254
protein-tyrosine kinases - metabolism (254) 254
treatment outcome (249) 249
genetic aspects (245) 245
protein-tyrosine kinase (245) 245
research (241) 241
patients (235) 235
analysis (234) 234
respiratory system (229) 229
young adult (225) 225
carcinoma, non-small-cell lung - pathology (224) 224
diagnosis (222) 222
abridged index medicus (221) 221
adenocarcinoma - genetics (217) 217
retrospective studies (217) 217
lymphoma, large-cell, anaplastic - drug therapy (215) 215
lymphoma, large-cell, anaplastic - diagnosis (208) 208
receptor protein-tyrosine kinases - antagonists & inhibitors (201) 201
adenocarcinoma of lung (191) 191
metastasis (190) 190
cell biology (189) 189
mice (189) 189
oncogene proteins, fusion - genetics (183) 183
neoplasm staging (180) 180
non-hodgkin's lymphomas (180) 180
diagnosis, differential (179) 179
erbb receptors - genetics (179) 179
proteins (179) 179
protein kinase inhibitors - pharmacology (178) 178
health aspects (175) 175
adenocarcinoma (169) 169
epidermal growth factor receptor (169) 169
medicine & public health (169) 169
translocation, genetic (167) 167
cancer therapies (164) 164
child, preschool (160) 160
antineoplastic combined chemotherapy protocols - therapeutic use (158) 158
gene expression (156) 156
aluminum compounds (155) 155
lymphoma, large-cell, anaplastic - enzymology (154) 154
biopsy (150) 150
dermatology (150) 150
surgery (148) 148
case report (146) 146
pyridines - therapeutic use (142) 142
pyrazoles - therapeutic use (141) 141
skin neoplasms - pathology (141) 141
tyrosine (141) 141
pharmacology & pharmacy (140) 140
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3493) 3493
Chinese (78) 78
Japanese (35) 35
French (18) 18
Korean (17) 17
German (11) 11
Russian (6) 6
Spanish (6) 6
Portuguese (2) 2
Italian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biochemical journal, ISSN 1470-8728, 05/2009, Volume 420, Issue 3, pp. 345 - 361
... (anaplastic lymphoma kinase) RTK was originally identified as a member of the insulin receptor subfamily of RTKs that acquires transforming capability when truncated and fused to NPM (nucleophosmin) in the t... 
Extracellular-signal-regulated kinase (ERK) | Pleiotrophin | Anaplastic large cell lymphoma (ALCL) | Neuroblastoma | Non-small cell lung cancer (NSLCL) | Midkine | Anaplastic lymphoma kinase (ALK) | Inflammatory myofibroblastic tumour (IMT) | Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Oncogene Proteins, Fusion - metabolism | Signal Transduction | Carcinoma, Non-Small-Cell Lung - genetics | Protein-Tyrosine Kinases - metabolism | Humans | Lung Neoplasms - metabolism | Neuroblastoma - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Lung Neoplasms - pathology | Nuclear Proteins - metabolism | Receptor Protein-Tyrosine Kinases | Protein-Tyrosine Kinases - genetics | Models, Biological | Oncogene Proteins, Fusion - genetics | Lymphoma, Large-Cell, Anaplastic - pathology | Neuroblastoma - metabolism | Nuclear Proteins - genetics | Lymphoma, Large-Cell, Anaplastic - metabolism | Neuroblastoma - pathology | Lymphoma, Large-Cell, Anaplastic - genetics | Index Medicus | ALK, anaplastic lymphoma kinase | LTK, leucocyte tyrosine kinase | MUC-1, mucin-1 | IRS-1, IR substrate-1 | PTN, pleiotrophin | TGFβ, transforming growth factor β | neuroblastoma | extracellular-signal-regulated kinase (ERK) | pleiotrophin | ERK, extracellular-signal-regulated kinase | PKB, protein kinase B | Shc, Src homology and collagen homology | TPM, tropomyosin | IMP cyclohydrolase | MK, midkine | MYH9, non-muscle myosin heavy chain | MAM, meprin, A5 protein and receptor protein tyrosine phosphatase mu | NPM, nucleophosmin | mTOR, mammalian target of rapamycin | NIPA, nuclear interacting partner of ALK | RPTP, receptor protein tyrosine phosphatase | inflammatory myofibroblastic tumour (IMT) | DLBCL, diffuse large B-cell lymphoma | FOXO3a, forkhead box O 3a | NF-κB, nuclear factor κB | Shp1, SH2 domain-containing phosphatase 1 | RANBP2, Ran-binding protein 2 | ALCL, anaplastic large cell lymphoma | Dpp, decapentaplegic | FRS2, fibroblast growth factor receptor substrate 2 | LDLa, low-density lipoprotein class A | EGFR, epidermal growth factor receptor | SEC31L1, SEC31 homologue A | GIST, gastrointestinal stromal tumour | RTK, receptor tyrosine kinase | SH2, Src homology 2 | TFG, TRK-fused gene | ATIC, 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase | midkine | CLTC, clathrin heavy chain | anaplastic large cell lymphoma (ALCL) | MAPK, mitogen-activated protein kinase | Hen-1, hesitation-1 | MEK, MAPK | PI3K, phosphoinositide 3-kinase | HEK, human embryonic kidney | SCD-2, suppressor of constitutive dauer 2 | Review | EBPβ, CCAAT | CARS, cysteinyl-tRNA synthetase | JNK, c-Jun N-terminal kinase | ERK kinase | Grb2, growthfactor-receptor-bound protein 2 | SCC, squamous cell carcinoma | EML4, echinoderm microtubule-associated protein like 4 | SHH, sonic hedghog | BCR-Abl, breakpoint cluster region-Abl | IR, insulin receptor | ALO17, ALK lymphoma oligomerization partner on chromosome 17 | enhancer-binding protein β | PLCγ, phospholipase Cγ | NSCLC, non-small cell lung cancer | UCN-01, unco-ordinated 1 | non-small cell lung cancer (NSLCL) | Cdc42, cell division cycle 42 | STAT, signal transducer and activator of transcription | anaplastic lymphoma kinase (ALK) | DRG, dorsal root ganglia | MSN, moesin | dALK, Drosophila ALK | IL-3, interleukin-3 | CNS, central nervous system | JAK, Janus kinase | CML, chronic myeloid leukaemia | Jeb, jelly belly | IMT, inflammatory myofibroblastic tumour
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 0027-8424, 9/2010, Volume 107, Issue 37, pp. 16228 - 16233
Journal Article
Journal Article
Cancer science, ISSN 1349-7006, 09/2019, Volume 110, Issue 10, pp. 3382 - 3390
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 08/2017, Volume 35, Issue 22, pp. 2490 - 2498
Journal Article
Leukemia, ISSN 1476-5551, 04/2008, Volume 22, Issue 6, pp. 1139 - 1143
Peripheral T-cell lymphomas (PTCLs) are fatal in the majority of patients and novel treatments, such as protein tyrosine kinase (PTK... 
Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Translocation, Genetic | Phosphorylation | Lymphoma, Extranodal NK-T-Cell - enzymology | Protein-Tyrosine Kinases - metabolism | Humans | Middle Aged | Child, Preschool | Male | Intracellular Signaling Peptides and Proteins - metabolism | Lymphoma, Large-Cell, Anaplastic - enzymology | Lymphoma, T-Cell, Cutaneous - genetics | Immunoenzyme Techniques | Lymphoma, Extranodal NK-T-Cell - genetics | Chromosomes, Human, Pair 9 - genetics | Protein-Tyrosine Kinases - genetics | Flow Cytometry | Aged, 80 and over | Adult | Female | Child | Intracellular Signaling Peptides and Proteins - genetics | Syk Kinase | Chromosomes, Human, Pair 5 - genetics | Lymphoma, Large-Cell, Anaplastic - genetics | Lymphoma, T-Cell, Peripheral - genetics | Immunophenotyping | In Situ Hybridization, Fluorescence | Blotting, Western | Lymphoma, T-Cell, Peripheral - enzymology | Lymphoma, T-Cell, Cutaneous - pathology | Lymphoma, T-Cell, Cutaneous - enzymology | Tyrosine - metabolism | Lymphoma, Extranodal NK-T-Cell - pathology | Lymphoma, T-Cell, Peripheral - pathology | Adolescent | Aged | Lymphoma, Large-Cell, Anaplastic - pathology | Control | T cell lymphoma | Protein tyrosine kinase | Genetic aspects | Research | Diagnosis | Gene expression | Drug therapy | Index Medicus | peripheral T-cell lymphoma | Syk | phosphorylation | tyrosine kinase
Journal Article